Home LiteratureArticle Details
PMID: 8006576 Published · ppublish English Comment Journal Article

Cancer antigens: immune recognition of self and altered self.

The Journal of experimental medicine ·Vol. 180 ·No. 1 ·1994-07-01 ·Pages 1-4

Houghton AN

Abstract

暂无摘要

MeSH Terms
Animals Antigens, Neoplasm/analysis,immunology Autoantigens/immunology T-Lymphocytes, Cytotoxic/immunology
Chemicals
Antigens, Neoplasm Autoantigens
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Houghton A N
Memorial Sloan-Kettering Cancer Center, New York.
References (21)
21 references, click to expand
  1. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
    J Exp Med. 1982 Dec 1;156(6):1755-66 PMID: 7175440
  2. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.
    J Exp Med. 1990 Apr 1;171(4):1375-80 PMID: 2324688
  3. Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.
    J Exp Med. 1990 Jul 1;172(1):35-45 PMID: 1694221
  4. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
    Science. 1991 Dec 13;254(5038):1643-7 PMID: 1840703
  5. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.
    Proc Natl Acad Sci U S A. 1989 Sep;86(18):7159-63 PMID: 2674949
  6. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
    J Exp Med. 1984 Oct 1;160(4):1219-33 PMID: 6237165
  7. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3515-9 PMID: 8170938
  8. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    J Exp Med. 1993 Aug 1;178(2):489-95 PMID: 8340755
  9. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.
    Cancer Res. 1992 Nov 15;52(22):6380-4 PMID: 1423285
  10. Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.
    Proc Natl Acad Sci U S A. 1978 Mar;75(3):1519-23 PMID: 274738
  11. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins.
    J Exp Med. 1991 Jan 1;173(1):273-6 PMID: 1670640
  12. Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene.
    Cancer Res. 1970 Oct;30(10):2458-62 PMID: 4097428
  13. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.
    J Exp Med. 1994 Mar 1;179(3):1005-9 PMID: 8113668
  14. Humoral immune responses to tumor-associated carbohydrate antigens.
    Semin Cancer Biol. 1991 Dec;2(6):421-31 PMID: 1725731
  15. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
    J Exp Med. 1994 Mar 1;179(3):921-30 PMID: 8113684
  16. Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells.
    Cell. 1989 Jul 28;58(2):293-303 PMID: 2568889
  17. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
    J Exp Med. 1991 Jun 1;173(6):1373-84 PMID: 1903428
  18. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
    Science. 1994 Apr 29;264(5159):716-9 PMID: 7513441
  19. Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.
    J Exp Med. 1983 Jun 1;157(6):1992-2001 PMID: 6602203
  20. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.
    Cancer Res. 1953 Dec;13(12):835-7 PMID: 13116120
  21. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.
    Cancer Res. 1994 Jan 1;54(1):16-20 PMID: 7505195
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1994-07-01
Pages
1-4
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2191545
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]